Optimal control analysis of combined chemotherapy-immunotherapy treatment regimens in a PKPD cancer evolution model
From MaRDI portal
Publication:5050555
DOI10.11145/j.biomath.2020.02.137zbMath1505.92094OpenAlexW3010544018MaRDI QIDQ5050555
Publication date: 17 November 2022
Published in: BIOMATH (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.11145/j.biomath.2020.02.137
Medical applications (general) (92C50) Existence theories for optimal control problems involving ordinary differential equations (49J15)
Related Items (6)
The impact of infected T lymphocyte burst rate and viral shedding rate on optimal treatment scheduling in a human immunodeficiency virus infection ⋮ Optimal control analysis of combined chemotherapy-immunotherapy treatment regimens in a PKPD cancer evolution model ⋮ Evolutionary game theory: Darwinian dynamics and the \(G\) function approach ⋮ Optimal control of effector-tumor-normal cells dynamics in presence of adoptive immunotherapy ⋮ An optimal control problem of immuno-chemotherapy in presence of gene therapy ⋮ Probabilistically certified region of attraction of a tumor growth model with combined chemo‐ and immunotherapy
Cites Work
- Unnamed Item
- Immunotherapy: an optimal control theory approach
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Optimal control applied to immunotherapy
- Differential equations. Classical to controlled
- Optimal control of treatments in a two-strain tuberculosis model
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- Optimal control analysis of combined chemotherapy-immunotherapy treatment regimens in a PKPD cancer evolution model
This page was built for publication: Optimal control analysis of combined chemotherapy-immunotherapy treatment regimens in a PKPD cancer evolution model
